In HeLa and HepG2 cancer cells, SSD greatly increased the amount of TNF-α-mediated cell death by inhibiting TNF-α-induced NF-κB activation and the expression of its target genes, which are involved in cancer cell survival, proliferation, invasion, and angiogenesis. This evidence concerns the gene NFKB1 and cancer.